Literature DB >> 2816285

Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy.

S Thorlacius1, J A Aarli, T Riise, R Matre, H J Johnsen.   

Abstract

The prevalence of myasthenia gravis (MG) in the counties of Hordaland and Sogn & Fjordane on January 1, 1984 was 9.6 per 100,000 inhabitants. Other autoimmune diseases were found in 11 out of 48 MG patients. The occurrence of autoimmune thyroiditis (5 patients, 10.4%) and systemic lupus erythematosus (4 patients, 8.3%) in the MG patients was clearly higher than that reported in the general population. Rheumatoid arthritis was found in 2 patients (4.2%). The autoimmune diseases were mainly recorded among the nonthymectomized MG patients. In addition to those with definite diseases of autoimmune nature, 3 other MG patients had thyroid antibodies and 1 had antinuclear factor without clinical evidence of autoimmune disease. Seven MG patients (14.6%) had unspecific arthralgia during active periods of MG. Two MG patients had ankylosing spondylitis.

Entities:  

Mesh:

Year:  1989        PMID: 2816285     DOI: 10.1111/j.1600-0404.1989.tb03881.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  17 in total

Review 1.  The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature.

Authors:  M Jallouli; D Saadoun; B Eymard; G Leroux; J Haroche; D Le Thi Huong; C De Gennes; C Chapelon; O Benveniste; B Wechsler; P Cacoub; Z Amoura; J C Piette; N Costedoat-Chalumeau
Journal:  J Neurol       Date:  2011-12-08       Impact factor: 4.849

2.  Coexistence of Behçet's disease and myasthenia gravis in a patient.

Authors:  Timur Pirildar
Journal:  Clin Rheumatol       Date:  2004-06-04       Impact factor: 2.980

3.  Myasthenia gravis coincident with papillary thyroid carcinoma: absent expression of the alpha-subunit of the acetylcholine receptor in the tumour.

Authors:  I Illa; N Vila; E Gallardo; F Graus
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

4.  Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients.

Authors:  M I Leite; E Coutinho; M Lana-Peixoto; S Apostolos; P Waters; D Sato; L Melamud; M Marta; A Graham; J Spillane; A M Villa; D Callegaro; E Santos; A Martins da Silva; S Jarius; R Howard; I Nakashima; G Giovannoni; C Buckley; D Hilton-Jones; A Vincent; J Palace
Journal:  Neurology       Date:  2012-05-02       Impact factor: 9.910

5.  Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001.

Authors:  J F Owe; A K Daltveit; N E Gilhus
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

6.  The repeated measurement of vital capacity is a poor predictor of the need for mechanical ventilation in myasthenia gravis.

Authors:  P Rieder; M Louis; P Jolliet; J C Chevrolet
Journal:  Intensive Care Med       Date:  1995-08       Impact factor: 17.440

7.  A population based epidemiological study on myasthenia gravis in Estonia.

Authors:  M Oöpik; A-E Kaasik; J Jakobsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

Review 8.  The association of systemic lupus erythematosus and myasthenia gravis.

Authors:  G Vaiopoulos; P P Sfikakis; V Kapsimali; K Boki; P Panayiotidis; A Aessopos; G C Tsokos; P Kaklamanis
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

9.  Coexistence of primary sclerosing cholangitis in a patient with myasthenia gravis.

Authors:  P J Lorenzoni; R H Scola; C S K Kay; D A Muzzillo; L C Werneck
Journal:  Ann Indian Acad Neurol       Date:  2011-10       Impact factor: 1.383

10.  Incidence of thymoma in myasthenia gravis: a systematic review.

Authors:  Zhi-Feng Mao; Xue-An Mo; Chao Qin; Yong-Rong Lai; Maree L Hackett
Journal:  J Clin Neurol       Date:  2012-09-27       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.